rx 821002 has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrocoso, E; Borges, GDS; Mico, JA; Torres-Sanchez, S | 1 |
1 other study(ies) available for rx 821002 and Alloxan Diabetes
| Article | Year |
|---|---|
Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain.
Topics: Action Potentials; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Idazoxan; Locus Coeruleus; Male; Naloxone; Neural Inhibition; Neurons; Pain Measurement; Rats; Tapentadol | 2018 |